# Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis

> **NCT02296346** · NA · TERMINATED · sponsor: **University of Utah** · enrollment: 13 (actual)

## Conditions studied

- Secondary Progressive Multiple Sclerosis

## Interventions

- **DRUG:** SoluMedrol
- **DEVICE:** Extracorporeal Photopheresis

## Key facts

- **NCT ID:** NCT02296346
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2017-06-13
- **Final completion:** 2018-05-10
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Low enrollment/PI relocated. New site couldn't reach agreement with manufacturer
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02296346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02296346, "Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02296346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*